Serotonin Norepinephrine
Reuptake Inhibitors (SNRIs)
SNRIs
Prof. Sawsan Aboul-Fotouh
Department of pharmacology, faculty of Medicine, Ain-Shams University
Serotonin Norepinephrine Reuptake
Inhibitors (SNRIs)
Venlafaxine Duloxetine Milnacipran
Desvenlafaxine Levomilnacipran
Mechanism of action of SNRIs
They are specific 5-HT and various
degrees NE reuptake inhibition.
Venlafaxine, at lower doses (75–100 mg/day) acts as
SSRI. As the dose increases it inhibit NE reuptake
(& 2ry ↓ DA reuptake in prefrontal cortex, which
lacks DAT→ ↑ DA).
Advantage & side effects of SNRIs
No Autonomic Blockade
H1 M
Adverse Effects
-Nausea, headache, sexual dysfunction, insomnia.
-Hypertension & ↑HR (in high dose). “NE”
(Stahl ҆s essential psychopharmacology, 2013)
Desvenlafaxine inhibits reuptake of NE > 5-HT
Desvenlafaxine has similar efficacy, indications, Pharmacodynamic
& Side effects as venlafaxine
Desvenlafaxine is not affected by CYP2D6 inducers & inhibitors
• Venlafaxine has half-life of ̴ 6 h and Desvenlafaxine has half-life of ̴ 12 h.
Duloxetine indicated in stress
urinary incontinence
Contraindications of Duloxetine
▪ Liver disease
▪ Severe renal impairment, end stage renal
disease (dialysis) (CrCl<30)
▪Moderate to heavy alcohol use.
Milnacipran and Levomilnacipran
Milnacipran
Therapeutic indications
(Stahl ҆s essential psychopharmacology, 2013)
A. FDA-approved
1. Fibromyalgia (Milnacipran only, 2009)
2. Major depressive disorder (Levomilnacipran only, 2013)
B. Non FDA-approved
1. Neuropathic pain/Chronic pain (Both)
Adverse Effects as SNRIs but More insomnia, & ↓appetite (as > ↑NE)
The 5-HT: NE ratios of SNRIs are: Venlafaxine = 30:1, Desvenlafaxine = 10:1, Duloxetine = 10:1,
Milnacipran = 1:1, and Levomilnacipran = 1:2 (Randy and Lori, 2014)
Q: Therapeutic Uses of SNRIs
1. Depressive disorders
2. Anxiety disorders (GAD, …….)
3. Post-traumatic stress disorder.
4. Neuropathic pain, Diabetic NP (Duloxetine , FDA 2004).
5. Fibromyalgia: (Duloxetine , 2008 & Milnacipran, 2009 ) and
Chronic musculoskeletal pain, (Duloxetine , FDA 2010).
6. Stress Incontinence (Duloxetine , off-label)
7. Vasomotor menopausal symptoms….